Expert articles on alzheimer's disease & dementia, clinical trial barriers, early diagnosis in Europe, plus ASH 2025 hematology conference coverage and oral health links to autoimmune disease.
Roche and Ascidian agree to $1.8bn neurological disease partnership
7 News
8 News
Researchers identify new major cause of inflammatory bowel disease
9 News
10 DERMATOLOGY NEWS
12 Brian D Smith Darwin’s MEDICINE McNamara’s Fallacy
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
13 Mike Dixon With compassion
14 GORDON DANIELS PUTTING AI TO WORK FOR PHARMA MARKETING LEADERS OF THE FUTURE
15 HEALTHCARE: How personalised healthcare will shape pharma’s role and reputation by 2030
16-18 Clinical trials on dementia: bridging access and innovation
Across almost every sector, brands are multiplying their investment in creativity
19 PM AWARDS
20-21 Alzheimer’s disease – the future of diagnosis and treatment in Europe
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
22-23 Oral health and systemic disease: why they may be more closely linked than we thought
24-26 ASH 2025
Picking your omnichannel direction requires a disciplined, scientific approach
27 Connecting through the chaos – why medical affairs needs creative problem-solving
28-29 Designing healthcare AI that works for every patient
30-31 TL SYNEOS HEALTH - Scaling AI in healthcare communications: from pilots to living systems
32 - 33 Pandemic readiness is now a financial risk test – and the UK must treat it that way